MedTrace Logo

Drainless Robot-assisted Minimally Invasive Esophagectomy

NCT05553795 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2024-06-13

No results posted yet for this study

Summary

The aim of this study is the evaluation of two different chest drain management strategies in patients undergoing robot-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer with regard to perioperative complications until discharge.The primary objective of the study is to investigate whether the intensity of postoperative pain can be significantly reduced by avoiding thoracic drains after RAMIE. We assume that this will influence secondary endpoints such as early recovery and length of hospital stay.

Conditions

  • Esophageal Cancer

Interventions

PROCEDURE

Early removal of chest drain

Chest drains are removed 3 hours after the end of surgery in absence of contraindications in arm A.

PROCEDURE

Chest drain

The chest drains in arm B are removed during the further postoperative course according to standard algorithm.

Sponsors & Collaborators

  • German Cancer Research Center

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Johanna Kirchberg, Dr. med. · Department of Gastrointestinal-, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-19
Primary Completion
2024-05-21
Completion
2024-05-21

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553795 on ClinicalTrials.gov